Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Trial of Sorafenib in BAC or Never-Smokers With Any Lung Adenocarcinoma

NCT00456716 is registered in ClinicalTrials.gov with Swedish Medical Center as lead sponsor.

NCT NCT00456716
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00456716 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Trial of Sorafenib in BAC or Never-Smokers With Any Lung Adenocarcinoma
Lead sponsor
Swedish Medical Center
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2007
Completion date
December 31, 2008
Enrollment
5 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer